Spine Biologics Market to Make Great Impact In Near Future by 2026
Pre-pregnancy genetic testing helps in identifying a problem of an unborn child before or during pregnancy. Pre-pregnancy genetic test is done to know the birth defects which are associated with genetic disorder or syndromes. Possibility of having a genetic disorder or birth defect could be due to the family or parents history of genetic disorder.
Some birth defects like Down syndrome, Trisomy 13 and Trisomy 18, are chromosome abnormalities that a child gets by having an extra chromosome in the sperm or egg. People with Down syndrome are prone to cardiac disorder or mild mental retardation. Babies with trisomy 13 and 18 have the same effects as Down syndrome and majority of them do not survive after 1 year of age. Spina bifida, which is a neural tube defect, happens when a baby’s spinal cord not fully developed and close into a tube. The chances are higher to have spina bifida if someone has a family history of the same. People suffering from it have partial paralysis, mental retardation or bladder issues.
Pre-Pregnancy Genetic Testing Market: Drivers & Restraints
Increasing awareness and preference for pre-pregnancy genetic testing, increase number of chromosomal abnormalities cases, increase spending per capita income, changing lifestyle, are key driving factor for this market. Furthermore, rising consumer awareness, rising demand of non-invasive pre-natal treatment, technology advancement and innovation, increasing healthcare expenditure, are some other key driving factors in pre-pregnancy genetic testing market. High accuracy and safety has led to increase in demand of pre-pregnancy genetic testing in developed and developing regions.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1408
With so many advantages and splendid features of pre-pregnancy genetic testing, it has few disadvantages too. High cost of the test is acting as a barrier for pre-pregnancy genetic market.
Pre-Pregnancy Genetic Testing Market: Segmentation
Pre-pregnancy genetic testing market is broadly classified on the basis of the following segments –
By Test Type:
- Chorionic Villi Sampling (CVS)
- Placental Biopsy
- Fetal Biopsy
- Carrier Screening
- Sequential Screening
- Maternal Serum Quad Screening
By End User:
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1408
Pre-Pregnancy Genetic Testing Market: Overview
The pre-pregnancy genetic testing market has grown substantially at a healthy CAGR due to growing high incidence rate of chromosomal abnormalities and increase popularity of pre-pregnancy genetic testing procedures. With rapid technological advancement and innovation, pre-pregnancy genetic testing market is expected to grow globally. North America is the largest market for pre-pregnancy genetic testing and Asia Pacific would be the fastest growing market in the forecast period.
Pre-Pregnancy Genetic Testing Market: Region-wise Outlook
The pre-pregnancy genetic testing market is expected to register a double-digit CAGR over the forecast period. Depending on geographic regions, pre-pregnancy genetic testing market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). North America is the largest market for pre-pregnancy genetic testing and is expected to dominate the market throughout the forecast period. Asia Pacific is the fastest growing region in the forecast period.
Browse Full Report@ http://www.futuremarketinsights.com/reports/spine-biologics-market
Pre-Pregnancy Genetic Testing Market: Key Players
Some of the key market players for genetic testing market are Sequenom Laboratories, Illumina, Inc, Natera, Inc, Ariosa Diagnostics, Inc, BGI Health, Natera and LifeCodexx.